Studies suggest GLP-1 drugs could be used to boost mood, cognitive function and alleviate symptoms among patients with Parkinsons, Alzheimers, dementia, bipolar disorder and anxiety.
participants from previous studies were invited back for a second MRI session
It non-selectively mimics the action of melanocortin peptides
It belongs to a class of medications called GLP-1 receptor agonists, which work by stimulating the release of insulin in response to high blood sugar levels, and by reducing the production of glucose by the liver
Eligibility typically depends on medical necessity, FDA-approved use, and meeting criteria like BMI thresholds and documented health conditions
Do not exceed the recommended daily intake